Robert King's Net Worth
$6.57 Million
Who is Robert King?
Robert King has an estimated net worth of $6.57 Million. This is based on reported shares across multiple companies, which include Alector, Inc., and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Robert King's CIK is 0001635264
Past Insider Trading and Trends
2016 was Robert King's most active year for acquiring shares with 6 total transactions. Robert King's most active month to acquire stocks was the month of September. 2020 was Robert King's most active year for disposing of shares, totalling 7 transactions. Robert King's most active month to dispose stocks was the month of July. 2021 saw Robert King paying a total of $549,000.00 for 154,541 shares, this is the most they've acquired in one year. In 2021 Robert King cashed out on 120,250 shares for a total of $1,873,422.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alector, Inc. (ALEC) Snapshot price: $6.415
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.08% | 21.58K |
—
|
—
| 550.87K |
Oct 1
| |||
Form 4
| -0.03% | -176.00 |
$10.62 | -$1,869.21 | 529.29K |
Sep 2
| |||
Form 4
| -0.03% | -177.00 |
$8.71 | -$1,541.58 | 529.47K |
Jun 2
| |||
Form 4
| -0.05% | -287.00 |
$15.57 | -$4,467.99 | 528.4K |
Mar 1
| |||
Form 4
| -0.05% | -250.00 |
$20.09 | -$5,022.50 | 528.69K |
Dec 1
| |||
Form 4/A
| +1.14% | 5.94K |
—
|
—
| 528.26K |
Oct 1
| |||
Form 4
| +1.53% | 7.97K |
—
|
—
| 530.28K |
Oct 1
| |||
Form 4
|
—
|
0
|
$20.15 | -$1,319,400.00 | 522.32K |
Scheduled
|
Jul 2
| ||
Form 4
| +9.43% | 45K |
—
|
—
| 522.32K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
| -3.05% | -15.00K |
$27.00 | -$404,957.58 | 477.32K |
Scheduled
|
May 15
| ||
Form 4
| -2.96% | -15.00K |
$29.56 | -$443,375.76 | 492.32K |
Scheduled
|
Feb 14
| ||
Form 4
| -2.87% | -15.00K |
$22.01 | -$330,150.00 | 507.32K |
Scheduled
|
Jan 21 - Jan 22
| ||
Form 4
| -1.42% | -7.50K |
$15.92 | -$119,400.00 | 522.32K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
| -1.40% | -7.50K |
$15.00 | -$112,500.00 | 529.82K |
Scheduled
|
Aug 19
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
SVP Prod. Dev/Supply Chain
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.47 | -$295,688.63 | 16.84K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||